IHS Chemical Week

Regions :: India/Pakistan

Ranbaxy’s API sales fall on lower demand

2:47 AM MST | February 7, 2014 | Deepti Ramesh

The active pharmaceutical ingredient (API) business of Ranbaxy Laboratories (Gurgaon, India) reports sales of 1.37 billion Indian rupees ($22 million) in the fourth quarter of 2013, compared with sales of Rs2.14 billion in the year-ago quarter. For the full year 2013, the API business reports sales of Rs6.92 billion, compared with sales of Rs7.30 billion in 2012. Sales in the API business were affected by lower demand, Ranbaxy says. Earnings figures for the API business were not disclosed. Last month, the US Food and Drug Administration (FDA) prohibited Ranbaxy...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa